Extracellular vesicles derived from SARS-CoV-2 M-protein-induced triple negative breast cancer cells promoted the ability of tissue stem cells supporting cancer progression

Introduction SARS-CoV-2 infection increases the risk of worse outcomes in cancer patients, including those with breast cancer. Our previous study reported that the SARS-CoV-2 membrane protein (M-protein) promotes the malignant transformation of triple-negative breast cancer cells (triple-negative BCC). Methods In the present study, the effects of M-protein on the ability of extracellular vesicles (EV) derived from triple-negative BCC to regulate the functions of tissue stem cells facilitating the tumor microenvironment were examined. Results Our results showed that EV derived from M-protein-induced triple-negative BCC (MpEV) significantly induced the paracrine effects of adipose tissue-derived mesenchymal stem cells (ATMSC) on non-aggressive BCC, promoting the migration, stemness phenotypes, and in vivo metastasis of BCC, which is related to PGE2/IL1 signaling pathways, in comparison to EV derived from normal triple-negative BCC (nEV). In addition to ATMSC, the effects of MpEV on endothelial progenitor cells (EPC), another type of tissue stem cells, were examined. Our data suggested that EPC uptaking MpEV acquired a tumor endothelial cell-like phenotype, with increasing angiogenesis and the ability to support the aggressiveness and metastasis of non-aggressive BCC. Discussion Taken together, our findings suggest the role of SARS-CoV-2 M-protein in altering the cellular communication between cancer cells and other non-cancer cells inside the tumor microenvironment via EV. Specifically, M-proteins induced the ability of EV derived from triple-negative BCC to promote the functions of non-cancer cells, such as tissue stem cells, in tumorigenesis.

[1]  Zunfu Ke,et al.  New insights into the correlations between circulating tumor cells and target organ metastasis , 2023, Signal transduction and targeted therapy.

[2]  P. Tayalia,et al.  In Vitro 3D Spheroid Model Preserves Tumor Microenvironment of Hot and Cold Breast Cancer Subtypes , 2023, Advanced healthcare materials.

[3]  Shuqun Zhang,et al.  Causal effects of COVID‐19 on cancer risk: A Mendelian randomization study , 2023, Journal of medical virology.

[4]  A. Acar,et al.  Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers , 2022, Scientific Reports.

[5]  M. Ikeguchi,et al.  Structure of SARS-CoV-2 membrane protein essential for virus assembly , 2022, Nature Communications.

[6]  C. Solbach,et al.  Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Obesity and the Tumor Microenvironment of Breast Cancer , 2022, Cancers.

[7]  A. Zloza,et al.  Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer Outcomes , 2022, bioRxiv.

[8]  P. K. Namboori,et al.  Association of SARS-CoV-2 infection and Triple Negative Breast Cancer (TNBC)-A Computational illustrative study , 2022, Letters in Drug Design & Discovery.

[9]  Ingmar Schoen,et al.  Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration , 2022, Journal of thrombosis and haemostasis : JTH.

[10]  T. Yamashita,et al.  SARS-CoV-2 M Protein Facilitates Malignant Transformation of Breast Cancer Cells , 2022, Frontiers in Oncology.

[11]  P. Gentile.  Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research , 2022, Biomedicines.

[12]  M. Zorzi,et al.  Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona , 2022, Annals of Oncology.

[13]  Q. Zhang,et al.  The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis , 2022, Frontiers in Immunology.

[14]  Changzheng Huang,et al.  Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance , 2021, Cancer cell international.

[15]  B. Bendok,et al.  Outcomes and Surgical Considerations for Neurosurgical Patients Hospitalized with COVID-19–A Multicenter Case Series , 2021, World Neurosurgery.

[16]  E. Ozyilmaz,et al.  COVID-19 patients’ sera induce epithelial mesenchymal transition in cancer cells , 2021, Cancer Treatment and Research Communications.

[17]  U. Hansmann,et al.  Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A , 2021, bioRxiv.

[18]  Joseph M. Johnson,et al.  N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection , 2021, Nature Communications.

[19]  R. Mathijssen,et al.  Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition , 2021, Frontiers in Immunology.

[20]  M. U. Rashid,et al.  SARS-COV-2 infection and lung tumor microenvironment , 2021, Molecular Biology Reports.

[21]  C. Harris,et al.  Cytokine Storms in Cancer and COVID-19 , 2020, Cancer Cell.

[22]  L. Zitvogel,et al.  The immuno-oncological challenge of COVID-19 , 2020, Nature Cancer.

[23]  T. Yamashita,et al.  Type 2 diabetes mellitus induced paracrine effects on breast cancer metastasis via extracellular vesicles derived from human mesenchymal stem cells. , 2020, Stem cells and development.

[24]  T. Gibson,et al.  Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease , 2020, Clinical chemistry.

[25]  A. Santoro,et al.  Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy , 2020, Cancers.

[26]  R. Hass.  Role of MSC in the Tumor Microenvironment , 2020, Cancers.

[27]  H. Randeva,et al.  Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19 , 2020, International journal of oncology.

[28]  Y. Xu,et al.  Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection , 2020, Frontiers in Cellular and Infection Microbiology.

[29]  H. Kikuchi,et al.  Tumor Endothelial Cell—A Biological Tool for Translational Cancer Research , 2020, International journal of molecular sciences.

[30]  Kunyu Yang,et al.  Elevations of serum cancer biomarkers correlate with severity of COVID‐19 , 2020, Journal of medical virology.

[31]  L. Roshangar,et al.  Tumor microenvironment complexity and therapeutic implications at a glance , 2020, Cell Communication and Signaling.

[32]  B. Zabel,et al.  Support of Tumor Endothelial Cells by Chemokine Receptors , 2019, Front. Immunol..

[33]  K. Pietras,et al.  The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence , 2018, Breast Cancer Research and Treatment.

[34]  Pia Siljander,et al.  Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum , 2018, Journal of extracellular vesicles.

[35]  M. Morimoto,et al.  Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance , 2017, Cancer science.

[36]  A. Zannetti,et al.  Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype , 2017, Oncotarget.

[37]  Li Li,et al.  The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond , 2017, Front. Endocrinol..

[38]  F. Wendler,et al.  Extracellular vesicles swarm the cancer microenvironment: from tumor–stroma communication to drug intervention , 2017, Oncogene.

[39]  S. Glynn,et al.  Mesenchymal stem cells: key players in cancer progression , 2017, Molecular Cancer.

[40]  Yufang Shi,et al.  Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets , 2016, Nature Reviews Drug Discovery.

[41]  Xiao-Liang Liu,et al.  Endothelial progenitor cells promote tumor growth and progression by enhancing new vessel formation , 2016, Oncology letters.

[42]  Lianghai Wang,et al.  Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14 , 2016, Scientific Reports.

[43]  S. Vacher,et al.  IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production , 2015, Oncotarget.

[44]  F. Gao,et al.  Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL‐6/gp130/STAT3 Pathway , 2015, Stem cells.

[45]  Ying Zhou,et al.  Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8 , 2015, Journal of experimental & clinical cancer research : CR.

[46]  C. Rodrigues,et al.  Endothelial Progenitor Cells in Tumor Angiogenesis: Another Brick in the Wall , 2015, Stem cells international.

[47]  J. Wiest,et al.  Endothelial cell tube formation assay for the in vitro study of angiogenesis. , 2014, Journal of visualized experiments : JoVE.

[48]  S. Lang,et al.  The bidirectional tumor - mesenchymal stromal cell interaction promotes the progression of head and neck cancer , 2014, Stem Cell Research & Therapy.

[49]  D. Martins‐de‐Souza,et al.  The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles , 2014, Proteomics.

[50]  T. Yamashita,et al.  The role of CCL5 in the ability of adipose tissue-derived mesenchymal stem cells to support repair of ischemic regions. , 2014, Stem cells and development.

[51]  S. Cheong,et al.  Endogenous Gastric-Resident Mesenchymal Stem Cells Contribute to Formation of Cancer Stroma and Progression of Gastric Cancer , 2013, Korean journal of pathology.

[52]  Yasuhiro Hida,et al.  Heterogeneity of tumor endothelial cells , 2013, Cancer science.

[53]  A. Schambach,et al.  Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. , 2013, Stem cells and development.

[54]  D. Scadden,et al.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. , 2013, The Journal of clinical investigation.

[55]  P. Kuo,et al.  The tumor microenvironment. , 2012, Surgical oncology.

[56]  R. Weinberg,et al.  Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. , 2012, Cancer discovery.

[57]  Jung Ah Cho,et al.  Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. , 2011, International journal of oncology.

[58]  Kathleen R. Cho,et al.  Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. , 2011, The Journal of clinical investigation.

[59]  G. Camussi,et al.  Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies. , 2010, Current vascular pharmacology.

[60]  Shahin Rafii,et al.  Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors , 2010, Nature Reviews Cancer.

[61]  C. Tognon,et al.  Reduced proliferation and enhanced migration: Two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1 , 2009, Cell cycle.

[62]  T. Schall,et al.  Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands , 2009, The Journal of Immunology.

[63]  S. Meuth,et al.  Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. , 2009, Journal of molecular and cellular cardiology.

[64]  X. Bian,et al.  Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft , 2009, Journal of Neuro-Oncology.

[65]  H. Friess,et al.  VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma , 2008, British Journal of Cancer.

[66]  C. Kielty,et al.  Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors , 2007, Journal of cellular and molecular medicine.

[67]  M. Shibuya,et al.  Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. , 2007, Blood.

[68]  D. Scheinberg,et al.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. , 2007, Genes & development.

[69]  A. Sapino,et al.  Isolation and characterization of human breast tumor-derived endothelial cells. , 2006, Oncology reports.

[70]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[71]  G. Watkins,et al.  Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer , 2005, Breast Cancer Research.

[72]  K. Klinger,et al.  Alterations in Vascular Gene Expression in Invasive Breast Carcinoma , 2004, Cancer Research.

[73]  D. Ota,et al.  Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2* , 2003, The Journal of Biological Chemistry.

[74]  J. Soria,et al.  SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. , 2000, Thrombosis research.

[75]  J. Nelson,et al.  Endothelium‐derived factors as paracrine mediators of prostate cancer progression , 2000, The Prostate.

[76]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[77]  G. Lilling,et al.  Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells , 1999, Journal of Cancer Research and Clinical Oncology.

[78]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[79]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[80]  J. Erusalimsky,et al.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.

[81]  R. Coombes,et al.  bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement. , 1995, The Biochemical journal.

[82]  L. Seymour,et al.  Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression , 1991, Breast Cancer Research and Treatment.

[83]  张欢欢,et al.  Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8. , 2015 .

[84]  C. Fan,et al.  Tumorigenesis and Neoplastic Progression Molecular Characterization of Human Breast Tumor Vascular Cells , 2008 .